Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.

Saved in:
Bibliographic Details
Title: Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.
Authors: Izadi Z; University of California, San Francisco., Gianfrancesco MA; University of California, San Francisco., Aguirre A; University of California, San Francisco., Strangfeld A; Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany., Mateus EF; Portuguese League Against Rheumatic Diseases, Lisbon, Portugal., Hyrich KL; The University of Manchester and National Institute for Health Research Manchester Biomedical Research Centre, Manchester University and NHS Foundation Trust, Manchester, UK., Gossec L; INSERM, Sorbonne Universite and Hopital Universitaire Pitie Salpetriere, AP-HP, Paris, France., Carmona L; Instituto de Salud Musculoesquelética, Madrid, Spain., Lawson-Tovey S; The University of Manchester and National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust and Manchester Academic Health Science Centre, Manchester, UK., Kearsley-Fleet L; The University of Manchester and Manchester Academic Health Science Centre, Manchester, UK., Schaefer M; German Rheumatism Research Center, Berlin, Germany., Seet AM; University of California, San Francisco., Schmajuk G; University of California, San Francisco and San Francisco Department of Veterans Affairs Medical Center., Jacobsohn L; University of California, San Francisco., Katz P; University of California, San Francisco., Rush S; University of California, San Francisco., Al-Emadi S; Hamad Medical Corporation, Doha, Qatar., Sparks JA; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Hsu TY; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Patel NJ; Massachusetts General Hospital and Harvard Medical School, Boston., Wise L; University of Southern California, Los Angeles., Gilbert E; Mayo Clinic, Jacksonville, Florida., Duarte-García A; Mayo Clinic, Rochester, Minnesota., Valenzuela-Almada MO; Mayo Clinic, Rochester, Minnesota., Ugarte-Gil MF; Universidad Científica del Sur and Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru., Ribeiro SLE; Universidade Federal do Amazonas, Manaus, Brazil., de Oliveira Marinho A; Fundação Hospitalar do Acre, Rio Branco, Brazil., de Azevedo Valadares LD; Universidade Federal de Pernambuco, Recife, Brazil., Giuseppe DD; Karolinska Institutet, Stockholm, Sweden., Hasseli R; Justus-Liebig University Giessen, Campus Kerckhoff, Giessen, Germany., Richter JG; Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Pfeil A; Jena University Hospital and Friedrich Schiller University Jena, Jena, Germany., Schmeiser T; Rheumatology im Veedel (Private Practice), Cologne, Germany., Isnardi CA; Argentine Society of Rheumatology, Buenos Aires, Argentina., Reyes Torres AA; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Alle G; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Saurit V; Hospital Privado Universitario de Córdoba, Córdoba, Argentina., Zanetti A; Italian Society for Rheumatology and University of Milano-Bicocca, Milan, Italy., Carrara G; Italian Society for Rheumatology and University of Milano-Bicocca, Milan, Italy., Labreuche J; Centre Hospitalier Universitaire de Lille, Lille, France., Barnetche T; FHU ACRONIM, Centre for Autoimmune Systemic Rare Diseases, Bordeaux University Hospital, Bordeaux, France., Herasse M; Filière des Maladies Autoimmunes et Autoinflammatoires Rares, Hôpital Huriez, Centre Hospitalier Universitaire de Lille, Lille, France., Plassart S; Filière des Maladies Autoimmunes et Autoinflammatoires Rares, Hôpital Huriez, Centre Hospitalier Universitaire de Lille, Lille, France., Santos MJ; Hospital Garcia de Orta, Almada, Portugal, and Instituto de Medicina Molecular Faculdade Medicina and Rheumatic Diseases Portuguese Register, Lisbon, Portugal., Rodrigues AM; Rheumatic Diseases Portuguese Register, Sociedade Portuguesa de Reumatologia, Nova Medical School, and Hospital dos Lusiadas, Lisbon, Portugal., Robinson PC; The University of Queensland, Brisbane, Queensland, Australia, and Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service, Herston, Queensland, Australia., Machado PM; University College London, University College London Hospitals NHS Foundation Trust and Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK., Sirotich E; McMaster University, Hamilton, Ontario, Canada, and Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada., Liew JW; Boston University School of Medicine, Boston, Massachusetts., Hausmann JS; Beth Israel Deaconess Medical Center, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts., Sufka P; HealthPartners, St. Paul, Minnesota., Grainger R; University of Otago, Wellington, Wellington, New Zealand., Bhana S; Pfizer Inc., New York, New York., Costello W; Irish Children's Arthritis Network, Tipperary, Ireland., Wallace ZS; Massachusetts General Hospital and Harvard Medical School, Boston., Yazdany J; University of California, San Francisco.
Corporate Authors: Global Rheumatology Alliance Registry
Source: ACR open rheumatology [ACR Open Rheumatol] 2022 Oct; Vol. 4 (10), pp. 872-882. Date of Electronic Publication: 2022 Jul 22.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101740025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-5745 (Electronic) Linking ISSN: 25785745 NLM ISO Abbreviation: ACR Open Rheumatol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first